BENZOTHIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS Russian patent published in 2024 - IPC C07D281/10 A61K31/554 A61P1/16 A61P3/06 A61P3/08 A61P9/00 

Abstract RU 2817535 C2

FIELD: chemistry.

SUBSTANCE: invention relates to 1,5-benzothiazepine derivatives of formula (I). In formula (I): each of R1 and R2 is independently C1-4 alkyl; R3 is independently selected from the group consisting of hydrogen, halogen, hydroxy, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, cyano, nitro, amino, N-(C1-4 alkyl) amino, N, N-di(C1-4 alkyl)amino and N-(aryl-C1-4alkyl)amino; n is integer 1, 2 or 3; R4 is selected from the group consisting of hydrogen, halogen, hydroxy, cyano, C1-4 alkyl, C3-6 cycloalkyl, C1-4 alkoxy, C3-6 cycloalkyloxy, C1-4 alkylthio, C3-6 cycloalkylthio, amino, N-(C1-4 alkyl) amino and N, N-di(C1-4 alkyl) amino; and each of R5A, R5B, R5C and R5D is independently selected from the group consisting of hydrogen, halogen, hydroxy, amino, C1-4 alkyl and C1-4 alkoxy; or a pharmaceutically acceptable salt thereof, provided that the compound is not racemic 3-((7-bromo-3-butyl-3-ethyl-1,1-dioxide-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepine-8-yl)oxy)propanoic acid. Invention also relates to a pharmaceutical composition containing said compounds and to use of said compounds as a medicinal agent.

EFFECT: disclosed compounds are bile acid modulators having activity of inhibiting apical sodium-dependent bile acid transporter (ASBT) and/or hepatic bile acid transport (LBAT) and can be used in the treatment of cardiovascular diseases, disorders of fatty acid metabolism and glucose utilization, gastrointestinal diseases, and liver diseases.

14 cl, 8 tbl, 52 ex

Similar patents RU2817535C2

Title Year Author Number
BENZOTHIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS 2020
  • Gillberg Per-Goran
  • Starke Ingemar
  • Kulkarni Santosh S.
RU2838460C1
BENZOTHIA(DI)AZEPINES AND THEIR USE AS BILE ACID MODULATORS 2019
  • Jillberg, Per-Jeran
  • Mattsson, Yan
  • Starke, Ingemar
  • Kulkarni, Santosh S.
RU2785867C2
BENZOTHIA(DI)AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS 2020
  • Gillberg Per-G&Ouml
  • Ran
  • Starke Ingemar
RU2827704C1
BENZOTHIA (DI) AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS 2020
  • Gillberg Per-Goran
  • Starke Ingemar
  • Kulkarni Santosh S.
RU2838220C1
BENZOTHIA(DI)AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS 2021
  • Gillberg, Per-Goran
  • Starke Ingemar
  • Kulkarni Santosh S.
RU2841263C1
BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACIDS MODULATORS 2020
  • Gillberg, Per-Joran
  • Mattson, Yan
  • Starke, Ingemar
  • Kulkarni, Santosh S.
RU2814570C2
BENZOTHIA(DI)AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS 2020
  • Gillberg Per-Goran
  • Starke Ingemar
  • Kulkarni Santosh S.
RU2837840C1
BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES USEFUL FOR TREATING NEOPLASTIC AND/OR INFECTIOUS DISEASES 2016
  • Ermann Monika
  • Lametshvandtner Gyunter
  • Amoutseg Patrisia Leoni
  • Kraft Rassell Styuart
  • Khanke Tomas
  • Dzhejms Timoti Robin
  • Dzhouns Severin Daniel
  • Lojbner Khans
  • Loke Puj Leng
  • Shternberger Ina
  • Shtyutts Anton
  • Ver Roland
  • Uittejker Mark
RU2730524C2
1,5-BENZOTHIAZEPINES AND EMPLOYMENT THEREOF AS ANTIHYPERLIPIDEMIC DRUGS 2001
  • Starke Ingemar
  • Dal'Strom Mikaehl'
  • Blomberg David
RU2302414C2
ORTHO-SUBSTITUTED DERIVATIVES OF BENZOIC ACID, METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND USING 2003
  • Li Lanna
RU2288912C2

RU 2 817 535 C2

Authors

Gillberg, Per-Joran

Mattson, Yan

Starke, Ingemar

Kulkarni, Santosh S.

Dates

2024-04-16Published

2020-02-06Filed